Dishman Carbogen Amcis Limited has informed the Exchange about Schedule of meet
DCAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dishman Carbogen Amcis Limited has notified the exchanges about a conference call scheduled for 20th May 2026 at 15:00 hrs IST to discuss Q4FY26 and FY26 financial results. The company will announce its quarterly and annual results on 19th May 2026. The call will be attended by Mr. Harshil Dalal (Global CFO) and Mr. Stephan Fritschi (CEO, Carbogen Amcis Entities). The company is a fully integrated CDMO (Contract Development and Manufacturing Organisation) serving global pharmaceutical innovators. This is a routine investor engagement communication filed under SEBI LODR Regulation 30.
This is a standard earnings-related disclosure with no immediate impact on the stock. However, investors may get insights into the company's performance trajectory and future guidance during the call.